Drugs Made in America AcquisDMAA
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 39 institutions reported holding Drugs Made in America Acquis (DMAA) in their 13F filings, unchanged from Q4 2025. 5 opened new positions and 6 sold out. The largest holders were Karpus Management, Inc. ($26.5M), First Trust Capital Management L.P. ($23.5M) and Mizuho Securities USA LLC ($20.9M). 2 famous investors held it, including David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Drugs Made in America Acquis
- CUSIP
- G2847J104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $19.8M |
| Exits | 6 | $18.1M |
All 13F filers, Q4 2025 → Q1 2026: 3,100,944 shares bought and 3,188,276 shares sold, net −87,332 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 39 holders
| Karpus Management, Inc. | 0.83% | Reduce -0.3% | 2,530,517 | $26.5M |
| First Trust Capital Management L.P. | 1.23% | No change | 2,242,500 | $23.5M |
| Mizuho Securities USA LLC | 0.49% | Add +39.5% | 2,000,000 | $20.9M |
| Glazer Capital, LLC | 0.39% | Reduce -7.6% | 1,678,406 | $17.6M |
| Westchester Capital Management, LLC | 0.85% | No change | 1,669,000 | $17.5M |
| Polar Asset Management Partners Inc. | 0.54% | No change | 1,600,000 | $16.8M |
| Wolverine Asset Management LLC | 0.86% | Add +18.8% | 1,553,708 | $16.3M |
| Highbridge Capital Management LLC | 1.34% | New | 1,323,351 | $13.9M |
| Aristeia Capital, L.L.C. | 0.36% | No change | 881,716 | $9.2M |
| D. E. Shaw & Co. | 0.01% | No change | 690,000 | $7.2M |
| Heights Capital Management, Inc. | 1.93% | No change | 650,000 | $6.8M |
| Shaolin Capital Management LLC | 0.64% | Add +172.2% | 550,000 | $5.8M |
| Radcliffe Capital Management, L.P. | 0.65% | No change | 546,808 | $5.7M |
| LMR Partners LLP | 0.06% | No change | 500,000 | $5.2M |
| Rivernorth Capital Management, LLC | 0.22% | No change | 417,998 | $4.4M |
| Whitebox Advisors LLC | 0.23% | No change | 400,000 | $4.2M |
| Meteora Capital, LLC | 0.30% | New | 380,299 | $4.0M |
| AQR Arbitrage LLC | 0.07% | Reduce -3.7% | 357,585 | $3.8M |
| RLH Capital LLC | 1.69% | — | 316,551 | $3.3M |
| Hudson Bay Capital Management LP | 0.02% | Reduce -80.8% | 297,833 | $3.1M |
| Quarry LP | 0.58% | No change | 266,551 | $2.8M |
| Context Capital Management, LLC | 0.71% | No change | 250,000 | $2.6M |
| Governors Lane LP | 0.33% | No change | 250,000 | $2.6M |
| Toronto Dominion Bank | 0.00% | Add +1.9% | 203,838 | $2.1M |
| L1 Global Manager Pty Ltd | 1.69% | No change | 200,000 | $2.1M |
| Sona Asset Management (us) LLC | 0.10% | New | 162,795 | $1.7M |
| Clear Street Group Inc. | 0.01% | Add +8.6% | 354,048 | $1.3M |
| Goldman Sachs Group Inc. | 0.00% | No change | 119,686 | $1.3M |
| DLD Asset Management, LP | 0.32% | No change | 100,559 | $1.1M |
| Warberg Asset Management LLC | 1.99% | Reduce 0.0% | 92,054 | $966K |
| Geode Capital Management, LLC | 0.00% | Add +36.4% | 62,273 | $654K |
| Periscope Capital Inc. | 0.10% | No change | 50,000 | $525K |
| JPMorgan Chase & Co. | 0.00% | Add +0.1% | 49,881 | $523K |
| Dakota Wealth Management | 0.01% | No change | 36,400 | $381K |
| Lineage Point Capital LP | 0.08% | No change | 31,840 | $334K |
| HRT Financial LP | 0.00% | Reduce -2.8% | 27,487 | $288K |
| BNP Paribas Financial Markets | 0.00% | New | 14,737 | $154K |
| Citadel Advisors | 0.00% | New | 10,476 | $110K |
| Morgan Stanley | 0.00% | Reduce -52.1% | 58 | $608 |
"% of holder's portfolio" is DMAA's weight in each manager's 13F, not the share of Drugs Made in America Acquis the manager owns.